Hope you are doing well.
Recently, I was scanning through some stocks and came across a company in which the promoters have been increasing stake year on year for more than 5 years now.
It is Sukhjit Starch & Chemicals. On reading further, found out that it is one of the oldest and the largest maize processing company specializing in production of starch and its derivatives.
Below, we have shared interesting insights from the Q4 FY 23 con-call of the company. Hope you find the details useful for your own investments or to add the stock to your watch list.
Before that, sometime back we released our new stock recommendation for our Alpha and Alpha + Members
We focus on growth oriented, owner operated small-mid cap companies that are trading at reasonable valuations and invest with a horizon of 3-4 years
The latest one fits our framework as it’s a sub 3,000 crore market cap stock, largest player in India in some of the Specialty chemicals it manufactures, introducing new import substitute products, expanded aggressively over the last 4-5 years, has good operating performance track record, started reducing debt and available at only 12.5 times last 5 years average net profit
You can get the above mentioned recommendations along with others, by subscribing HERE
Sukhjit Starch & Chemicals – Insights from Q4 FY 23 con-call of the company
– About Business
- We are an agro-processing company that specializes in production of starch and its derivatives
- Our operations started in 1943; Since then we have been expanding and currently we operate at four locations within India
- We initially started with 1,800 tons per annum of corn grind capacity, which at present is around 600,000 tons per annum
- Our product range includes native starches, modified starches, dextrines, liquid glucose, high maltose syrup, maltodextrins, monohydrate dextrose, sorbitol, dextrose anhydrous, etc.
- These compounds serve as a purpose in manufacturing a variety of products like candies, toothpastes, protein powders, flavoring agents, medicines, cosmetics and many more.
- The efficient operation and resource management of our four plants have resulted in all facilities operating at approximately 80% capacity
– Future Plans
- Expanding our presence across different geographies has been a key objective for our company
- To address evolving customer demands, we have focused on optimizing our product mix with a particular emphasis on high value offerings
- To fuel our growth trajectory, we have allocated capital expenditure to enhance the capacity of our existing plants. This strategic investment will increase our daily production capacity installed from 1,600 tons to 2,000 tons over the next 24 months
- We are targeting around INR 40 crores (CAPEX) for this financial year
- Our industry grows at more than the rate of GDP. That has been the general trend and has been a consistent trend over the last many years. So we hope to continue with that. That’s the bare minimum
- The intent is there to keep growing and our capex is targeted at ensuring that our future growth keeps happening
– Starch Industry
- At Sukhjit, we are at approximately between 9% to 11% of market share depending on many estimates
- There is a fair degree of consolidation amongst the top four or five players and the rest is fragmented
- There are only a few listed players and amongst those listed players, I would expect that between 50% to 60% of the market share could be covered
- As far as the future outlook of our industry is concerned, starch consumption per capita in India is one-tenth of that of US and one-fifth of that of China
- Indian total output, Maize crop output is not more than 30 million tons. Some say 35 million tons. So exact data is not there
- As a thumb rule, I would say the poultry and the feed industry consumes roughly between 60% to 70%
- As far as exports are concerned, yes, that also fluctuates. It’s not a consistent 10% every year
- Between the 20% left, some of maize goes into direct foods and some maize goes into the starch industry
- High fructose corn syrup – Our parallel is with Brazil, not with US. US uses high fructose corn syrup because it does not have sugar plantations. India has adequate sugar so it will always be at the forefront
Disclaimer: This is not a recommendation to buy/sell Sukhjit Starch & Chemicals. The securities quoted are for illustration only and are not recommendatory.
SEBI Research Analyst Registration No. INH100001690
Research Analyst Details
Name: Ekansh Mittal Email Id: [email protected] Ph: +91 727 5050062
Details of Associate: Not Applicable
Analyst Certification: The Analyst certify (ies) that the views expressed herein accurately reflect his (their) personal view(s) about the subject security (ies) and issuer(s) and that no part of his (their) compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report.
Address – 7, Panch Ratan, 7/128, Swaroop Nagar, Kanpur – 208002, Contact No. – +91-7275050062
Compliance Officer – Mr. Ekansh Mittal, +91-9818866676, ekansh@
Grievance Redressal – Mittal Consulting, grievances@
“Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors”.
“Investment in securities market are subject to market risks. Read all the related documents carefully before investing.”
The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision
This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. Ekansh Mittal/Mittal Consulting/Katalyst Wealth is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Ekansh Mittal or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither Ekansh Mittal, nor its employees, agents nor representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. Ekansh Mittal/Mittal Consulting or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement.
The recipients of this report should rely on their own investigations. Ekansh Mittal/Mittal Consulting and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. Mittal Consulting has incorporated adequate disclosures in this document. This should, however, not be treated as endorsement of the views expressed in the report.
We submit that no material disciplinary action has been taken on Ekansh Mittal by any regulatory authority impacting Equity Research Analysis.
Disclaimer: You can access it here – LINK
Whether the research analyst or research entity or his associate or his relative has any financial interest in the subject company/companies and the nature of such financial interest – No
Whether the research analyst or research entity or his associates or his relatives have actual/beneficial ownership of 1% or more securities of the subject company (at the end of the month immediately preceding the date of publication of the research report or date of the public appearance) – No
Whether the research analyst or research entity or his associate or his relative has any other material conflict of interest at the time of publication of the research report or at the time of public appearance – No
Whether it or its associates have received any compensation from the subject company in the past twelve months – No
Whether it or its associates have managed or co-managed public offering of securities for the subject company in the past 12 months – No
Whether it or its associates have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months – No
Whether it or its associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months – No
Whether the subject company is or was a client during twelve months preceding the date of distribution of the research report and the types of services provided – No
Whether the research analyst has served as an officer, director or employee of the subject company – No
Whether the research analyst or research entity has been engaged in market making activity for the subject company – No